ShedRx vs Peak Wellness
Two GLP-1 desks, one scoreboard. We put ShedRx and Peak Wellness head-to-head on the published Brief Score — the same six factors, scored the same way, no pay-to-win placement.
The verdict
ShedRx takes this head-to-head.
ShedRx scores 87 to 83 on our six-factor Brief Score — A weight-focused program with a low tracked tirzepatide rate and an oral/sublingual route for the needle-averse.
That doesn't make Peak Wellness a bad call — it's best for readers drawn to a consumer-brand experience who are comfortable vetting an unaccredited desk themselves. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| ShedRx | Peak Wellness | |
|---|---|---|
| Brief Score | 87/100 (B+) | 83/100 (B) |
| Semaglutide | $199/mo | $249/mo |
| Tirzepatide | $299/mo | $349/mo |
| Coverage | Not disclosed | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
| On the tracker | Fallingprice falling | Stableprice stable |
ShedRx: Competitive tirzepatide rate trimmed further this cycle — cheapest tirz among our partner desks.
Peak Wellness: $249 sema / $349 tirz nationwide; no accreditation listed.
● Not sold on either?
CoreAge Rx tops the whole board at 94/100.
The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.